Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-029479
Filing Date
2021-07-22
Accepted
2021-07-22 16:46:41
Documents
1
Period of Report
2021-07-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 14736
  Complete submission text file 0000899243-21-029479.txt   16100
Mailing Address C/O ALNYLAM PHARMACEUTICALS, INC 300 THIRD STREET CAMBRIDGE MA 02142
Business Address
Westphal Christoph H (Reporting) CIK: 0001291961 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40603 | Film No.: 211108095

Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Issuer) CIK: 0001783328 (see all company filings)

EIN.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)